Dr Teshirogi of JPMA Expresses Concern About Impact of New Price Reduction Rule on Stable Supplies of Long-Listed Drugs, Generics

Isao Teshirogi, President, JPMA In a regular briefing with reporters on January 15, Isao Teshirogi, president of the Japan Pharmaceutical Manufacturers Association (JPMA), expressed concern about the possible impact of the new NHI price reduction rule for long-listed drugs, particularly...read more